Valeant Calls Short Seller's Report Erroneous After Stock Falls

Updated on
  • Drugmaker says no benefit when pharmacies hold inventory
  • Shares recover ground after falling as much as 40 percent

Valeant Calls Short Seller's Report 'Erroneous'

Valeant Pharmaceuticals International Inc. said a short seller’s allegation that it recorded fake sales to phony customers was “erroneous,” mounting a defense of its relationship with specialty pharmacies that failed to assuage investors.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.